Literature DB >> 11142525

Bowel movement, use of laxatives and risk of colorectal adenomatous polyps among women (United States).

L Dukas1, E A Platz, G A Colditz, W C Willet, E L Giovannucci.   

Abstract

BACKGROUND: Infrequent bowel movements and use of laxatives have been hypothesized to increase risk of colorectal neoplasia. However, the few existing epidemiologic studies in humans have been inconclusive.
PURPOSE: To investigate prospectively the associations of bowel movement frequency and laxative use with the occurrence of adenomatous colorectal polyps in women.
METHODS: A total of 17,400 women 36-61 years of age, without previous diagnosis of cancer or polyps, responded to a mailed questionnaire in 1982 that assessed bowel movement frequency and use of laxatives and had an endoscopy between 1984 and 1996. Between 1984 and 1996, 906 cases of adenomatous polyps (496 classified as small (< 1 cm), 358 classified as large (> or = 1 cm) and 52 unclassified) were documented. Relative risks (RRs) of adenomas and 95% confidence intervals (CIs) were calculated using logistic regression.
RESULTS: After controlling for adenoma risk factors, the multivariate RRs associated with having bowel movements every third day or less compared to once daily were 0.9 (95% CI: 0.7-1.2) for total colorectal adenomas, 1.0 (95% CI: 0.7-1.5) for large adenomas and 1.0 (95% CI: 0.7-1.3) for adenomas of the colon only. The multivariate RRs associated with weekly to daily laxative use compared to never use were 0.9 (95% CI: 0.7-1.1) for total colorectal adenomatous polyps, 1.0 (95% CI: 0.7-1.5) for large adenomas and 0.8 (95% CI: 0.6-1.2) for colon adenomatous polyps only.
CONCLUSION: These findings do not support an association between infrequent bowel movement or laxative use and risk of colorectal adenomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11142525     DOI: 10.1023/a:1026559624330

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  7 in total

1.  Multiple behavioral factors are associated with occurrence of large, flat colorectal polyps.

Authors:  Tianzuo Zhan; Felix Hahn; Thomas Hielscher; Asmé Bilge; Jürgen Grüger; Jürgen Weers; Johannes Betge; Timo Gaiser; Georg Kähler; Matthias P Ebert; Sebastian Belle
Journal:  Int J Colorectal Dis       Date:  2016-11-28       Impact factor: 2.571

2.  Chronic constipation and co-morbidities: A prospective population-based nested case-control study.

Authors:  Rok S Choung; Enrique Rey; G Richard Locke; Cathy D Schleck; Charles Baum; Alan R Zinsmeister; Nicholas J Talley
Journal:  United European Gastroenterol J       Date:  2015-11-11       Impact factor: 4.623

3.  The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.

Authors:  Einat Avital Schmutz; Michael Bruce Zimmermann; Sabine Rohrmann
Journal:  Eur J Nutr       Date:  2015-02-21       Impact factor: 5.614

4.  Prospective cohort studies of bowel movement frequency and laxative use and colorectal cancer incidence in US women and men.

Authors:  Xuehong Zhang; Kana Wu; Eunyoung Cho; Jing Ma; Andrew T Chan; Xiang Gao; Walter C Willett; Charles S Fuchs; Edward L Giovannucci
Journal:  Cancer Causes Control       Date:  2013-03-02       Impact factor: 2.506

5.  Five-year follow-up of 263 cases of functional bowel disorder.

Authors:  Yu-Rong Tang; Ping Wang; Rui Yin; Jian-Xin Ge; Guo-Pin Wang; Lin Lin
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

Review 6.  Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients.

Authors:  C K Chang; C M Ulrich
Journal:  Diabetologia       Date:  2003-05-23       Impact factor: 10.122

7.  A prospective study of the effect of bowel movement frequency, constipation, and laxative use on colorectal cancer risk.

Authors:  Jessica Citronberg; Elizabeth D Kantor; John D Potter; Emily White
Journal:  Am J Gastroenterol       Date:  2014-09-16       Impact factor: 10.864

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.